BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 18803133)

  • 1. Selected mutations in the myosin binding protein C gene in the Polish population of patients with hypertrophic cardiomyopathy.
    Rudziński T; Selmaj K; Drozdz J; Krzemińska-Pakuła M
    Kardiol Pol; 2008 Aug; 66(8):821-5; discussion 826-7. PubMed ID: 18803133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertrophic cardiomyopathy in a Portuguese population: mutations in the myosin-binding protein C gene.
    Cardim N; Perrot A; Santos S; Morgado P; Pádua M; Ferreira S; Reis RP; Monteiro C; Ferreira T; Correia JM; Osterziel KJ
    Rev Port Cardiol; 2005 Dec; 24(12):1463-76. PubMed ID: 16566405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy.
    Girolami F; Olivotto I; Passerini I; Zachara E; Nistri S; Re F; Fantini S; Baldini K; Torricelli F; Cecchi F
    J Cardiovasc Med (Hagerstown); 2006 Aug; 7(8):601-7. PubMed ID: 16858239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy.
    Van Driest SL; Vasile VC; Ommen SR; Will ML; Tajik AJ; Gersh BJ; Ackerman MJ
    J Am Coll Cardiol; 2004 Nov; 44(9):1903-10. PubMed ID: 15519027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in the cardiac myosin-binding protein C gene are the predominant cause of familial hypertrophic cardiomyopathy in eastern Finland.
    Jääskeläinen P; Kuusisto J; Miettinen R; Kärkkäinen P; Kärkkäinen S; Heikkinen S; Peltola P; Pihlajamäki J; Vauhkonen I; Laakso M
    J Mol Med (Berl); 2002 Jul; 80(7):412-22. PubMed ID: 12110947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diastolic dysfunction without left ventricular hypertrophy is an early finding in children with hypertrophic cardiomyopathy-causing mutations in the beta-myosin heavy chain, alpha-tropomyosin, and myosin-binding protein C genes.
    Poutanen T; Tikanoja T; Jääskeläinen P; Jokinen E; Silvast A; Laakso M; Kuusisto J
    Am Heart J; 2006 Mar; 151(3):725.e1-725.e9. PubMed ID: 16504640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy.
    Van Driest SL; Jaeger MA; Ommen SR; Will ML; Gersh BJ; Tajik AJ; Ackerman MJ
    J Am Coll Cardiol; 2004 Aug; 44(3):602-10. PubMed ID: 15358028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Micro-exons of the cardiac myosin binding protein C gene: flanking introns contain a disproportionately large number of hypertrophic cardiomyopathy mutations.
    Frank-Hansen R; Page SP; Syrris P; McKenna WJ; Christiansen M; Andersen PS
    Eur J Hum Genet; 2008 Sep; 16(9):1062-9. PubMed ID: 18337725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations profile in Chinese patients with hypertrophic cardiomyopathy.
    Song L; Zou Y; Wang J; Wang Z; Zhen Y; Lou K; Zhang Q; Wang X; Wang H; Li J; Hui R
    Clin Chim Acta; 2005 Jan; 351(1-2):209-16. PubMed ID: 15563892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene-specific modifying effects of pro-LVH polymorphisms involving the renin-angiotensin-aldosterone system among 389 unrelated patients with hypertrophic cardiomyopathy.
    Perkins MJ; Van Driest SL; Ellsworth EG; Will ML; Gersh BJ; Ommen SR; Ackerman MJ
    Eur Heart J; 2005 Nov; 26(22):2457-62. PubMed ID: 16087648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and spectrum of mutations in a cohort of 192 unrelated patients with hypertrophic cardiomyopathy.
    Millat G; Bouvagnet P; Chevalier P; Dauphin C; Jouk PS; Da Costa A; Prieur F; Bresson JL; Faivre L; Eicher JC; Chassaing N; Crehalet H; Porcher R; Rodriguez-Lafrasse C; Rousson R
    Eur J Med Genet; 2010; 53(5):261-7. PubMed ID: 20624503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy.
    Carrier L; Bonne G; Bährend E; Yu B; Richard P; Niel F; Hainque B; Cruaud C; Gary F; Labeit S; Bouhour JB; Dubourg O; Desnos M; Hagège AA; Trent RJ; Komajda M; Fiszman M; Schwartz K
    Circ Res; 1997 Mar; 80(3):427-34. PubMed ID: 9048664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac myosin binding protein-C mutations in families with hypertrophic cardiomyopathy: disease expression in relation to age, gender, and long term outcome.
    Page SP; Kounas S; Syrris P; Christiansen M; Frank-Hansen R; Andersen PS; Elliott PM; McKenna WJ
    Circ Cardiovasc Genet; 2012 Apr; 5(2):156-66. PubMed ID: 22267749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel cardiac myosin-binding protein C S297X mutation in hypertrophic cardiomyopathy.
    Hirota T; Kubo T; Kitaoka H; Hamada T; Baba Y; Hayato K; Okawa M; Yamasaki N; Matsumura Y; Yabe T; Doi YL
    J Cardiol; 2010 Jul; 56(1):59-65. PubMed ID: 20350521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives.
    Andersen PS; Havndrup O; Hougs L; Sørensen KM; Jensen M; Larsen LA; Hedley P; Thomsen AR; Moolman-Smook J; Christiansen M; Bundgaard H
    Hum Mutat; 2009 Mar; 30(3):363-70. PubMed ID: 19035361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A substitution mutation in the myosin binding protein C gene in ragdoll hypertrophic cardiomyopathy.
    Meurs KM; Norgard MM; Ederer MM; Hendrix KP; Kittleson MD
    Genomics; 2007 Aug; 90(2):261-4. PubMed ID: 17521870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-myosin heavy chain: a sarcomeric gene associated with dilated and hypertrophic phenotypes of cardiomyopathy.
    Carniel E; Taylor MR; Sinagra G; Di Lenarda A; Ku L; Fain PR; Boucek MM; Cavanaugh J; Miocic S; Slavov D; Graw SL; Feiger J; Zhu XZ; Dao D; Ferguson DA; Bristow MR; Mestroni L
    Circulation; 2005 Jul; 112(1):54-9. PubMed ID: 15998695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mutations in sarcomeric genes MYH7, MYBPC3, TNNT2, TNNI3, and TPM1 in patients with hypertrophic cardiomyopathy].
    García-Castro M; Coto E; Reguero JR; Berrazueta JR; Alvarez V; Alonso B; Sainz R; Martín M; Morís C
    Rev Esp Cardiol; 2009 Jan; 62(1):48-56. PubMed ID: 19150014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a novel MYBPC3 gene variant in a patient with hypertrophic cardiomyopathy.
    Brion M; Allegue C; Gil R; Blanco-Verea A; Carracedo A; Pagannone E; Evangelista A; Di Castro S; Marchitti S; Stanzione R; Volpe M; Rubattu S
    Ann Clin Lab Sci; 2010; 40(3):285-9. PubMed ID: 20689143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homozygous mutation of MYBPC3 associated with severe infantile hypertrophic cardiomyopathy at high frequency among the Amish.
    Zahka K; Kalidas K; Simpson MA; Cross H; Keller BB; Galambos C; Gurtz K; Patton MA; Crosby AH
    Heart; 2008 Oct; 94(10):1326-30. PubMed ID: 18467358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.